Prevention of sepsis following endoscopic retrograde cholangiopancreatography

J Hosp Infect. 1991 Sep:19 Suppl C:65-70. doi: 10.1016/0195-6701(91)90169-9.

Abstract

Ora; ciprofloxacin was studied as a prophylactic antimicrobial agent in high- and low-risk patients undergoing endoscopic retrograde cholangiography. Ciprofloxacin appeared to be effective, good serum levels were attained, and the drug compared favourably on grounds of cost and convenience with a parenterally-administered cephalosporin.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Cefazolin / administration & dosage
  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
  • Ciprofloxacin / administration & dosage
  • Ciprofloxacin / therapeutic use*
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Risk Factors
  • Sepsis / etiology
  • Sepsis / prevention & control*

Substances

  • Ciprofloxacin
  • Cefazolin